{"url_path":"/sec/pgny/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 OTHER INFORMATION","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-08","source_url":"https://www.sec.gov/Archives/edgar/data/1551306/0001551306-26-000068-index.html","accession_number":"0001551306-26-000068","cik":"0001551306","ticker":"PGNY","issuer_name":"Progyny, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1551306/0001551306-26-000068-index.html","primary_entity_key":"0001551306","primary_entity_name":"Progyny, Inc."},"word_count":98,"has_tables":true,"body_markdown":"ITEM 5. OTHER INFORMATION\n\na.None.\n\nb.None.\n\nc.During the three months ended March 31, 2026, certain of our officers and directors adopted or terminated Rule 10b5-1 trading arrangements as follows:\n\nOn January 26, 2026, Peter Anevski, our Chief Executive Officer, terminated the trading plan that was intended to satisfy the conditions under Rule 10b5-1(c) of the Exchange Act adopted by him on March 31, 2025. The plan provided for the sale of up to 1,244,220 shares of the Company’s common stock in amounts and prices determined in accordance with a formula set forth in the plan.\n\n66\n\n[Table of](#id9afbabdceed4c78b2e77c21e334c072_7)[contents](#id9afbabdceed4c78b2e77c21e334c072_7)"}